BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 550751)

  • 1. [Detection of HBsAg and the related antibody (HBsAb) with the radioimmunological method. Behavior of the HBeAg-HBcAb system in HBsAg-positive patients].
    Ortona L; Pizzigallo E; Federico G; Camilli G
    Arch Sci Med (Torino); 1979; 136(4):509-22. PubMed ID: 550751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Further observations on the HBeAg-HBeAb system in the course of hepatitis and in HBsAg carriers].
    Ortona L; Pizzigallo E; Federico G
    Minerva Med; 1979 Feb; 70(9):647-54. PubMed ID: 108636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunological investigation (HBsAg, HBsAb, HBcAb) and its significance for reducing the risk of hepatitis B transmission through blood (author's transl)].
    Novák J; Kselíková M
    Cas Lek Cesk; 1979 Oct; 118(40-41):1235-8. PubMed ID: 393397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on a new hepatitis B antigen-antibody system: e-anti-e.
    Ortona L; Pizzigallo E; Federico G; Camilli G; Scian J
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):467-75. PubMed ID: 597398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Routine screening for serological markers of viral hepatitis B in pregnancy].
    Podrouzek P; Mancal P; Kozlová J; Labohá J
    Cesk Gynekol; 1989 Sep; 54(8):575-80. PubMed ID: 2582501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.